TrialDiabetologia2014

Influence of TCF7L2 gene variants on the therapeutic response to the dipeptidylpeptidase-4 inhibitor linagliptin.

Heike Zimdahl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.